Objective-Clinical trials of bone marrow-derived stem cell therapy for the heart have yielded variable results. The basic mechanism(s) that underlies their potential efficacy remains unknown. In the present study, we evaluated the survival kinetics, transcriptional response, and functional outcome of intramyocardial bone marrow mononuclear cell (BMMC) transplantation for cardiac repair in a murine myocardial infarction model. Methods and Results-We used bioluminescence imaging and high-throughput transcriptional profiling to evaluate the in vivo survival kinetics and gene expression changes of transplanted BMMCs after their engraftment into ischemic myocardium. Our results demonstrate short-lived survival of cells following transplant, with less than 1% of cells surviving by 6 weeks posttransplantation. Moreover, transcriptomic analysis of BMMCs revealed nonspecific upregulation of various cell regulatory genes, with a marked downregulation of cell differentiation and maturation pathways. BMMC therapy caused limited improvement of heart function as assessed by echocardiography, invasive hemodynamics, and positron emission tomography. Histological evaluation of cell fate further confirmed findings of the in vivo cell tracking and transcriptomic analysis. Conclusion-Collectively, these data suggest that BMMC therapy, in its present iteration, may be less efficacious than once thought. Additional refinement of existing cell delivery protocols should be considered to induce better therapeutic efficacy. (Arterioscler Thromb Vasc Biol. 2012;32:92-102.)
Although both animal and human studies have attempted to address mechanisms underlying cardiac cell therapy, 16 -19 a detailed exploration of BM cell survival kinetics in the setting of acute ischemic injury remains lacking. The interplay between the host environment and transplanted cells has not been studied in detail, and the early cellular response following cell delivery and implantation at a transcriptional level remains unknown. In this study, we aimed to address some of the aforementioned issues, primarily to investigate the efficacy of bone marrow mononuclear cell (BMMC) therapy for acute myocardial disease.
We used a clinically relevant model of acute myocardial ischemia-reperfusion (I/R) injury, coupled with molecular imaging techniques, to test our hypothesis that the limited efficacy of cell therapy demonstrated in clinical trials may be the result of poor posttransplant cell survival. We further characterized the effects of the ischemic cardiac milieu on transplanted cell behavior by gene expression analysis, revealing a marked downregulation of differentiation pathways in BMMCs transplanted into the injured heart. Finally, we used multimodality functional assays, such as echocardiography, positron emission tomography (PET), and invasive hemodynamics, to test whether BMMC therapy induces any improvement in cardiac function in the setting of acute ischemic injury.
Materials and Methods

Animals
Adult female FVB mice (nϭ97, The Jackson Laboratory, Bar Harbor, ME) and male L2G reporter transgenic mice (nϭ40, Stanford University, Stanford, CA) were used. Transgenic animals were created on the FVB background to constitutively express both firefly luciferase (Fluc) and enhanced green fluorescence protein (eGFP) driven by a constitutive ubiquitin promoter in all tissues and organs, including BM cell populations. Animal care was provided in accordance with the Stanford University School of Medicine guidelines and policies for the use of laboratory animals.
Study Design
A diagrammatic overview of the study is given in Supplemental Figure I , available online at http://atvb.ahajournals.org. Specifically, female FVB mice were mechanically ventilated with 2% to 3% isoflurane and 100% O 2 and randomized into 2 groups: (1) ischemia/reperfusion (I/R) injury (nϭ69) by occlusion of left anterior descending coronary artery for 45 minutes and (2) sham procedure with open thoracotomy and placement of peri-left anterior descending suture but no left anterior descending occlusion (nϭ28). I/R animals (nϭ36) received 5ϫ10 6 BMMCs (harvested from male L2G85 transgenic donors) via 3 direct intramyocardial injections at the infarct border zones with a total volume of 50 L using a 29-gauge Hamilton syringe. Sham (nϭ28) animals were injected with 5ϫ10 6 BMMCs at 3 places at the anterolateral wall. A subset of the I/R animals (nϭ33) received 50 L of PBS in a similar distribution to serve as controls for cardiac functional analyses. Operations were performed by a microsurgeon with several years of experience with this model. Cell therapy was monitored by optical bioluminescence imaging (BLI) on days 2, 4, 7, 10, 14, 21, and 48 using D-luciferin (300 mg/g body weight, delivered intraperitoneally). BLI results were validated ex vivo by reverse transcriptionpolymerase chain reaction analysis for the male Sry gene. Transplanted cells were harvested from a subset of animals in both I/R (nϭ9) and sham (nϭ8) groups 4 days following delivery by explanation of the heart followed by collagenase digestion and fluorescence-activated cell sorting-based collection of green fluorescent protein (GFP) ϩ cells. RNA was harvested and used for microarray analysis. Cardiac function was assayed by echocardiography, PET imaging, and invasive pressure-volume loop analysis. Histological analysis was performed on randomly selected hearts (nϭ5) to determine BMMC fate.
Preparation of BMMCs
BMMCs were harvested from the long bones of male L2G transgenic mice and isolated by centrifugation in a density cell separation medium (Ficoll-Hypaque) before cardiac injection as previously described. 20
BLI of BMMC Transplantation
BLI was performed using the Xenogen In Vivo Imaging System (Alameda, CA) as previously described. 21 See Supplemental Methods for further details.
Validation of BLI by Polymerase Chain Reaction Analysis of BMMC-Injected Hearts Ex Vivo
For ex vivo validation of BLI, a standard curve was first generated by correlating cycle counts from real-time polymerase chain reaction probing for the male Sry gene in female hearts injected with known numbers of male BMMCs as previously described. 22 See Supplemental Methods for further details.
Microarray Analysis of Injected BMMCs
Heart-BMMC complexes were harvested from I/R (nϭ5) and sham (nϭ4) groups 4 days after transplantation and subjected to collagenase digestion on a Langendorff apparatus as previously described. 23 The resultant cell slurry was fluorescence-activated cell sorted, and 40 000 to 100 000 eGFP ϩ cells were collected for RNA isolation (RNeasy purification columns, Qiagen). RNA purity was confirmed by analysis on the Agilent 2100 Bioanalyzer using RNA Pico Chips (Agilent, Sunnyvale, CA). RNA was amplified using 2 rounds of linear amplification (Agilent amplification kit) per the manufacturer's instructions. RNA hybridizations were performed using the Agilent Mouse (Development) Oligo Microarray G4120A platform, consisting of 20 371 60-mer oligonucleotides representing more than 20 000 known mouse genes and derived largely from sequences from the National Institute on Aging cDNA 7.4K and 15K mouse clone sets. 24 A common reference consisting of RNA derived from whole 17.5-day mouse embryos was used as previously described. 25 Significance analysis of microarrays was performed in a 2-class, unpaired fashion to identify genes that were significantly up-or downregulated between I/R and sham groups, using a false discovery rate cutoff of 5%. Gene lists were analyzed with the Web-based DAVID 26 and GoMiner 27 cluster-function analysis tools to identify enriched categories of gene ontology (PϽ0.05 by the Fisher exact test, with murine background). Proprietary software (Agilent, Menlo Park, CA) was used to generate ball-and-stick gene tree diagrams relating parent-daughter relationships between Gene Ontology (GO) terms, degree of significance of GO term up-or downregulation, and number of genes significantly up-or downregulated within a GO term.
Echocardiographic Determination of Left Ventricular Contractility
Please refer to the Supplemental Methods section.
PET Analysis
A subset of animals from both I/R (BMMC and PBS groups; nϭ11/group) underwent myocardial PET imaging using [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) radiotracer. Imaging was acquired with the P4 Concorde MicroPET system. Animals were injected with [ 18 F]FDG (144Ϯ33 Ci), and images from 60 to 75 minutes after injection were reconstructed by filtered back-projection algorithm. Myocardial perfusion was calculated as region of interest-derived [ 18 F]FDG percentage injected dose per gram of tissue as previously described. 28 See Supplemental Methods for further details.
Invasive Cardiovascular Hemodynamics
Animals receiving either BMMC (nϭ15) or PBS (nϭ13) following I/R injury were assayed 6 weeks after surgery. Please refer to the Supplemental Methods section for further details.
Flow Cytometry Analysis
Tissue Fixation and Immunohistochemical Analysis
Statistical Analysis
Experimental results are expressed as meanϮSEM. Linear regression analysis was performed to determine correlation between 2 variables. Repeated-measures ANOVA with post hoc testing and nonpaired Student t test were used where appropriate. The level of significance was defined as PϽ0.05. Microarray statistical analysis was carried out as described above.
Results
In Vitro Analysis of BMMCs Shows Robust Reporter Gene Expression
We have previously described the L2G transgenic mice, which constitutively express both the Fluc and eGFP reporter
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Transcriptional Profiling of BMMC Fate in Heart genes. 20, 22 Cells derived from these mice can be easily tracked when transplanted into wild-type mice by wholebody BLI (Fluc) or histological sections (eGFP). To confirm prior reports and establish that L2G-derived BMMCs were similar to genetically unmodified wild-type BMMCs, we performed marrow phenotyping by fluorescence-activated cell sorting analysis. Approximately 0.058Ϯ0.009% of the mononuclear cell fraction possessed the classical hematopoietic stem cell phenotype (Lin Ϫ , c-kit ϩ , Sca-1 ϩ ; Figure 1A and 1B). More than 90% of this population expressed GFP ( Figure 1C ). L2G-derived marrow also possessed the classical fractions of CD8 ϩ and CD4 ϩ cells ( Figure 1D and 1E ).
Granulocyte and B-cell lineage cells were also present within the L2G marrow ( Figure 1F ), as were a typical proportion of mesenchymal cells, defined as CD11b Ϫ , CD45 Ϫ , Sca-1 ϩ , CD44 ϩ ( Figure 1G reporter gene expression assays. More than 90% of L2G cells exhibited robust eGFP, compared with no detectable fluorescence in wild-type-derived marrow ( Figure 2E ). eGFP expression was confirmed by direct confocal microscopy of cells immediately following harvest, demonstrating strong and uniform eGFP expression within the cytosol ( Figure 2F ). Luciferase reporter gene activity was assessed by in vitro imaging of BMMCs as well as by firefly luciferase assay. Imaging of known concentrations of cells revealed a robust correlation between cell number and BLI signal ( Figure 2G and 2H; r 2 ϭ0.99). In vitro firefly luciferase assay yielded similar results ( Figure 2I ), with a significant correlation between cell number and Fluc expression (r 2 ϭ0.98).
In Vivo Imaging of BMMCs Transplanted Into Normal and Ischemic Myocardium Reveals Differential Patterns of Survival
To elucidate the survival kinetics of BMMCs transplanted into the acutely injured heart, BLI was used to image cell fate for up to 6 weeks following transplantation ( Figure 3A ). In both noninjured and ischemia-reperfusion-injured hearts, cell signal followed a quadratic trend over time, peaking at day 4, and falling significantly by day 10 through 21 (multivariate ANOVA, Pϭ0.001; Figure 3B We detected similar results of cell loss compared with the cardiac I/R injections (Supplemental Figure II) . Furthermore, to evaluate the hypothesis that a high degree of early cellular engraftment predicts efficacy of therapeutic outcome, we used BLI data measured on day 2 after transplant as a surrogate measure of cellular engraftment and stratified the BMMC transplant recipients into high-versus lowengraftment groups. Indeed, BLI signal intensity at day 2 correlated well with long-term survival and left ventricular function as assessed by echocardiography at week 6 (Supplemental Figure III) .
In Vitro and In Vivo TaqMan Analysis Correlates With BLI
To validate and confirm the quantitative analysis of transplanted cell survival, we correlated BLI results to an established ex vivo methodology of quantifying cell survival following transplant, namely TaqMan quantitative reverse transcription-polymerase chain reaction. To produce a standard curve, we performed quantitative reverse transcriptionpolymerase chain reaction, probing for the Sry sequence in the genomic DNA isolated from whole female hearts injected with known numbers of male BMMCs ex vivo. Analysis revealed a robust correlation between cycle count and the number of transplanted male cells (r 2 ϭ0.99, Figure 4A ). We then examined hearts taken from animals following BMMC injection and BLI at various days posttransplantation and thereby demonstrated a strong linear correlation between threshold cycle count and BLI signal (r 2 ϭ0.99, Figure 4B , left vertical axis). Construction of this correlation curve then allowed for extrapolation of surviving cell number based on BLI signal ( Figure 4B , right vertical axis). By this technique, the lower limit of cell detection was on the order of 1ϫ10 2 cells, similar to prior reports for BLI imaging within the thorax. 20, 22 
Microarray Analysis of Transplanted Cells
To gain insight into the transcriptional changes occurring within BMMCs after delivery into ischemic myocardium, we isolated them from explanted hearts and performed comprehensive transcriptional profiling analysis. Specifically, gene regulation was evaluated as a function of I/R injury, comparing the transcription response of cells injected into injured hearts against those injected into normal (sham-operated) animals. Fluorescence-activated cell sorting of Langendorffdigested I/R and sham heart cells resulted in collection of 40 000 to 100 000 GFP ϩ cells per heart (Supplemental Figure  IV) . Approximately 1200 genes were found to be significantly upregulated when comparing I/R versus shamoperated hearts, and 200 genes were significantly downregulated ( Supplemental Tables I and II ; q-value Ͻ0.05). Functional cluster analysis by DAVID and GoMiner onlineanalysis yielded numerous up-and down-regulated enriched functional groups (full list of functional groups with degree of significance given in Supplemental Table III) . Functional groups were further subsorted into Molecular Function (Figure 5A) and Biological Processes ( Figure 5B ). The greatest number of genes upregulated within the Molecular Function category were subsets of the nucleotide binding, transferase activity, ligase activity, and enzyme regulator activity GO terms. Analogous genes were found to be similarly upregulated within Biological Process, notably within the following GO terms: establishment of localization, RNA metabolism, cell cycle, and macromolecule biosynthesis. Downregulated genes were clustered within Biological Processes categories, with no significant downregulation observed in Molecular Function. Analysis of significantly downregulated genes was revealing. Specifically, they included numerous genes involved in cell differentiation, cell fate commitment, development, pattern specification, and Wnt signaling, suggesting that the ischemic environment of the host myocardium may hamper initiation of developmental, differentiation, and maturation pathways.
Histological Evaluation Supports Findings of Molecular Imaging and Microarray Analysis
After in vivo imaging, we performed histological analysis of explanted hearts at various time points following transplantation. As reported in prior studies, 22, 29 transient occlusion of the left anterior descending artery resulted in a typical pattern of I/R injury with transmural involvement of the myocardium in regions supplied by the main branches of the left coronary artery ( Figure 6A ). L2G-derived BMMCs were clearly pres- 
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ent in the infarcted areas with a cytosolic pattern of GFP expression ( Figure 6B and 6C ). Evaluation of hearts harvested at 6 weeks postimplantation did not reveal persistent BMMCs (data not shown). As predicted by transcriptional profiling analysis, staining for cardiac-specific markers such as troponin ( Figure 6D ) and connexin ( Figure 6E ) revealed no histological evidence of transdifferentiation by the BMMCs at day 7 posttransplant. These findings are in agreement with those described in previous reports. 30, 31 
Multimodality Assessment of Cardiac Function Following I/R Injury
Given the mixed results of prior studies (both animal and clinical) evaluating cardiac function following BMMC transplant, 32, 33 we chose to use multimodality analysis to determine whether BMMC transplantation improved myocardial function in our model. Echocardiography was used to assess myocardial function, whereas PET perfusion imaging was used to evaluate possible changes in myocardial perfusion. Echocardiography ( Figure 7A ) revealed a significant decrease in fractional shortening 2 weeks after I/R injury in both PBS-treated (51.3Ϯ5.0% to 34.1Ϯ3.8%, PϽ0.05) and
BMMC-treated groups (49.8Ϯ4.0% to 36.1Ϯ3.9%, PϽ0.05).
There was a trend toward preserved fractional shortening in the BMMC group through week 6, although this did not reach statistical significance (37.9Ϯ2.5% versus 34.2Ϯ2.7%, PϭNS). Evaluation of diastolic and systolic function by echocardiographic assessment of left ventricular end-diastolic dimension and end-systolic dimension revealed a similar trend toward improvement of diastolic and contractile dynamics of BMMC-treated hearts ( Figure 7B and 7C) . Invasive hemodynamics confirmed our echocardiographic findings, revealing no statistically significant difference in end-diastolic and end-systolic volumes at week 6 ( Figure 7D, top row) , although a trend toward improvement was observed in the BMMC-treated group.
Other measurements of cardiac output and contractility, such as left ventricular time relaxation constant (), end-systolic elastance, and end-systolic pressure-volume relationship, were also similar between PBS-and BMMC-treated groups ( Figure  7D, bottom panels) . Finally, PET [ 18 F]FDG imaging analysis also revealed no significant increase in myocardial viability following BMMC transplant. Although PET signal was mildly increased in hearts treated with BMMCs compared with PBS alone (Figure 7E) , the difference in viability signal did not achieve statistical significance (13.6Ϯ4.1 versus 11.7Ϯ3.5% injected dose per gram of tissue, PϭNS).
Discussion
Since its introduction as a therapeutic concept more than 10 years ago, BMMC therapy has been initiated in a variety of formats worldwide. Most clinical trials have yielded mixed results. 32, 33 Two metaanalysis of 18 and 10 trials, respectively, evaluating the effect of intracoronary infusion of BMMCs for the treatment of acute myocardial infarction have shown marginal benefits at best (Ϸ3%-4% increase in left ventricular ejection fraction). 34, 35 Given that autologous cell preparations represent a therapeutic product of far greater complexity than traditional drugs, in-depth study of their in vivo behavior is required. However, despite the ongoing clinical work, detailed molecular analyses of BMMCs after transplantation into myocardium remain unknown. In particular, little is known regarding the early biological activity of BMMCs following their delivery into a novel myocardial environment, including the early transcriptional events that might dictate cell survival and therapeutic efficacy.
In the present study, we have attempted to address these issues and provide insight as to how BMMC therapy can be improved for enhanced success in the clinic realm (Supplemental Figure I ). We used molecular techniques and a clinically relevant model of acute ischemic myocardial injury to demonstrate that (1) the ischemic myocardial environment induces a proliferative response in the transplanted cell population, but long-term engraftment is limited; (2) transcriptional profiling of cells transplanted into the heart reveals upregulation of numerous housekeeping and cell proliferation genes but a marked downregulation of pathways regulating differentiation and maturation; and (3) transplanted cells induce a mild, transient improvement in cardiac function that does not appear to be long-lasting.
Our molecular imaging results confirm earlier observations from cell therapy studies using chronic ischemia models that cell survival is, at best, limited to a few weeks. 20, 22 Several other investigators have postulated that limited survival may partially explain why BMMC therapy has not achieved the success suggested by early animal studies. 32, 36, 37 This observation highlights 1 of the major hurdles facing BMMC therapy in that, even in ideal conditions such as our control animal group (ie, syngeneic, noninjured myocardium), transplanted cell grafts persisted for a limited time in host tissue. These survival data also raise concern regarding the hypothesis that improvement in cardiac function following cell therapy may be due to secretion of paracrine factors by the transplanted cells. 38, 39 If paracrine signaling is a primary mechanism underlying improved cardiac function, intuitively long-term secretion from a sufficient number of surviving cells would be more beneficial for sustained benefit.
Although long-term survival of BMMCs following acute ischemic injury is limited, early posttransplantation cell behavior appears a dynamic and active process. Using molecular imaging and gene profiling techniques, we were able to discern a differential pattern of early posttransplant survival and proliferation of BMMCs in the I/R injured hearts as compared with nonischemic myocardium, confirming previous findings. 21 The implication that the inflammatory nature of the postinfarcted myocardium may affect transplanted cell behavior is rather intuitive and there is evidence to show that the intense inflammatory reaction occurring after myocardial infarction may produce chemokines responsible for lymphocyte tracking and stem cell homing to the damaged myocardium. 22, 40 However, the postinfarct inflammatory milieu also appears to have a dual effect. On the one hand, it serves to activate homing and promote a proliferative response among transplanted cells, as observed in the present study. On the other hand, it may create a hostile environment, resulting in indiscriminate cellular activation and turning cells away from stable maturation fates. 21, 31 Given the results of the present study, investigations into the optimal BM cell fraction, cell dose, timing, and delivery modality are expected to add much-needed insight into an improved strategy for making cell transplantation an effective therapeutic tool. 41 In addition, understanding the response of transplanted cells to their new host environment will be essential to exploit the possible therapeutic potential of BMMCs. It is with this premise that we chose to examine the early transcriptional events within BMMCs as described in this study.
The gene-profiling findings presented here represent a novel dataset in the growing body of literature examining BMMC therapy for heart disease. To our knowledge, this is the first study evaluating the transcriptional response of BMMCs in the ischemic heart. Our GO analysis shows that the overwhelming cellular response to transplantation is to simply survive in the new environment rather than activate pathways implicated in engraftment and long-term survival. Specifically, we saw no significant activation of long-term proliferation, differentiation, or maturation pathways in the transplanted BMMCs. Rather, BMMCs activated macromolecule synthesis and cellular machinery genes, suggesting a fraught attempt to mitigate cell death. Of particular interest are the GO terms demonstrating the most robust upregulation, such as cell cycle, cytoskeletal protein binding, and establishment of localization. These groups encompass genes responsible for rapid cell growth and division, confirming the cell behavior observed through BLI and lending credence to the notion of a provocative inflammatory milieu. Of equal importance are the findings of significantly downregulated groups of genes clustering in the areas of development, cell differentiation, pattern specification, and cell fate commitment. These provide transcriptional-level evidence that BM-MCs were not able to adopt mature cardiac phenotypes shortly after transplantation in our acute ischemia model. 30 However, the interpretation of the array analysis has some limitations. BMMCs are a heterogeneous cell population representing portions of hematopoietic cells, as well as macrophages, granulocytes, and natural killer cells. 20 Therefore, we cannot completely exclude the possibility that the changes observed in the array data may be affected by changes in the surviving cell population over the time as opposed to transcriptional changes in specific cell populations. Additional studies injecting purified cell populations or using microfluidic single-cell PCR technique 42 would be needed to tease out the transcriptomic response of specific cell lineages.
In summary, we present a multimodal evaluation of BMMC therapy in a clinically relevant animal model. We have detailed the earliest transcriptional events following transplant, described long-term transplanted cell survival kinetics, and characterized the eventual effects on cardiac function following transplant. Our findings mirror present clinical experience, which shows limited functional improve-ment following BMMC therapy. 33, 34 The survival data provided by BLI suggest that therapeutic efficacy may be limited by insufficient cell survival, whereas our genomic data suggest very active transplanted cellular machinery responding to an acutely inflamed host tissue environment. Successful therapy generating long-term improvement in cardiac function may very well depend on modulation of both the host environment and the transplanted cell transcriptional response to ensure optimal BMMC engraftment and survival. 
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